De Bellis E, Imbergamo S, Candoni A, Lico A, et al. Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803]. Leuk Res 2022 Feb 23:106811. doi: 10.1016/j.leukres.2022.106811.
PMID: 35219543